July 14 (SeeNews) - The three Bulgarian plants of Iceland-based generic drug maker Actavis had a combined net profit of 1.4 million levs ($1.0 million/716,000 euro) last year, down from 20 million levs a year earlier, local buisness wire Investor.bg reported on Tuesday.
Jun 10, 2026
BucharestJun 30, 2026Marrakech
